INTRODUCTION
Light has recently been reported to be a useful tr eatment in affective illness (1, 2, 3, 4, 5, 6) . What type of patients respond to thi s type of treatment ? Wh at is the theoretical mechanism of action of light therap y a nd what are the impl icat ions of th is research for the existing theories of affective illness? Th is review will seek answers to these questions by summarizing th e recentl y reported studies of the effects of light on depression , by reviewing the pertinent contributions from neuroan atomy, endocrin ology and circ adian rhythm physiology, and, finall y, by sugges ting some points of integration of these recent findings with existing th eories of depression.
HISTORICAL ASPECTS OF SEASONAL MOOD CH ANGES
Hippocrates wrote : "If any violent cha nge has occurre d in the air according to seasons , the brain becomes different from what it was" (7) . Hellpach, in 1911, was the first in modern medical literature to notice the existe nce of seaso nal mood changes in manic-depressive patients (I). Kraeplin, in 1921 , agreed with Hellpach and further described such patients as follows: "Repeatedly I saw moodiness set in in the a utumn and pass over in the spring, when the sa p shoots in th e trees to excitemen t, corresponding in a certain sense to the chang es which come over even health y individuals at the changes of the seasons" (8) . Several recent epidemiological studies have shown seasonal variation in the preponderance of affective illness, with peak rat es for depression (both unipolar and bipolar) in the spring and fall of the year, and peak rates for suicide in the summer months (1,9, 10, 11).
The length of day , or photoperiod, is one variable th at may be linked with seasonal variations of depression in susceptible individuals.
USING LIGHT TO TREAT DEPRESSION
The first case of using artificial light in the treatment of affective illness was reported by Lewy, et al (2) . The subject was a sixty-three-yea r-old male, diagnosed by Dr. Miller is a f ourth-year resident . 6 Research Diagnostic Criteria (13) as having a bipolar-II major depressive disord er, who had not responded to a variety of antidepressa nt dru gs due to intolerable side effects. The patient kept a diar y for fourteen years docum enting a history of: hypom anias beginning in Januar y or Februa ry of each yea r, eac h lasting an average of 22 weeks; and of depressions beginning in Jul y of each yea r, eac h lasting at least 29 weeks. Dur ing December 1980, sixteen weeks into a depressive episode, he was exposed to fluorescent light (Vitalite) of 2000 lux intensity between his time of awakening at 6:00 until 9:00 A.M . and again between 4:00 and 7:00 P.M ., thus extending his photoperiod to thirteen hours (i.e., a spring photoperiod compared to a ten-hour December photoperiod with dawn at 7:00 A .M . and du sk at 5:00 P.M .). After four day s of this regimen, the patient a ppeared markedly impr oved with Visual Analog Mood Scale self-ratings increasing from (+ -S. D.) 20( + -2) to 39( + -I) (50 = euthymia) . Nurses' ratings of depression declined significa ntly and 24-hour activi ty counts increased from a mean of 4748 to 7003 .
Rosenthal and colleagues reported a case of a twent y-nine-year-old woman who reg ularly suffered depressions every winter and hypomani as every spring since earl y adolescence (1). These cycles were strongly effected by the relative latitude of her residence, i.e., the further north she lived, the earlier her fall depr essions began with more severe and long lasting symptoms. Earl y morning light thera py was reportedly used successfully beginning in August when her depr essive cycle began, and this therapy reportedl y continued to be beneficial during the fall and winter for four years of follow-up .
A more systematic study was subsequently done by Rosenthal et al (I). Eleven subjects were screened from 2000 a pplica nts who respond ed to a news article describing the a bove patient. For inclusion in th e study the patients had to have a history of major affective disorder according to RDC criteria ( 13) , with onset in the fall or winter for at least two consecutive yea rs a nd subsequent remissions in the following spring or summer. Patients were then followed with reg ular clinic visits until the y began to feel depressed (assessed by self-report , clinica l interview, and Hamilton and Beck Depression Rating Scales). When pati ent s becam e modera tely depressed for two weeks, the y were offered experimental light tr eatment. Two kinds of light were used: a) bright full spectrum fluorescent light, a pproxima tely 2500 lux at 90 cm; and b) dim yellow fluorescent light of 100 lux intensity at 90 em (used as a control). Patients were requested to sit in front of the light s doing some activity other than sleeping for three hour s before dawn and three hour s after dark. A crossover study was performed such that if clinical improvement was noted after two weeks of eithe r bright or dim light therapy both lights were withdrawn for one week before the alternate light therapy was begun. Improvement was defined by psychiatric intervi ew and a Hamilton Score of less than fiftee n. If no improvement was noted after two weeks the second regimen was begun without delay .
Results showed that those patients treated with bright white light showed significant antidepressant effects with a mean Hamilton Rating Scale ( H RS) pret reatment score of 17.7 + -3.7 and a postreatment score of 6.7 + -5. 1 (p < .001) . Those patients exposed to dim light (control) showed a nonsignificant change in mean HRS score from a pretreatment baseline of 15.41 + -4.6 to 13 + -7.1. Th ere was a sta tistica l difference in the change in HRS score induced by bright whit e light versus dim yellow light (p < .0 I) when a paired t test was performed. Seven patients requested to be restarted on the bright light regimen at th e end of the crossover study, and first and second responses to light treatment were simila r in all cases. Mood improvement with bright light was noted within three to seven days of thera py, and relapse occurre d to a significa nt degree (t = 3.29; P < .0 1; two tailed paired t test) after withdrawal of the light within three to four days on the average.
CHARACTERISTICS OF RESPONDERS TO LIGHT TH ERAPY
Seventy-six percent of Rosenthal's patients were diagnosed as bipolar-II and seventeen percent as bipolar-I, though man ia was not a selection criterion. One-th ird of the pat ients had never received psychiatric treatmen t and only three had been previously hospitalized suggesti ng that Seasonal Affective Disorder (SAD) may be a mild vari ant of manic -depression as Kraeplin had originally sta ted (7). Rosenthal further point s out that SAD seems to be a bipolar varia nt of so-called "atypica l" depression with frequent symptoms of hyper somn ia, hyperphagia, carbohydr ate craving, and weight gai n.
Th e outs ta ndi ng clin ical feature of SAD , noted by Rosenthal a nd colleag ues, was a sensitivity to changes in season or lat itud e that cor responded to the a pproxima te annua l occurrence of affective episodes. O f Rosentha l's patients, 83% described their moods as worsening with nort hward trav el and sym ptom amelioration a fter traveling south (wit hin the northern hemisphere). T he prevalence of seasonal exacerb ations in manic-depr essive pat ient s was noted by Kraeplin to be four or five percent (7). Rosenthal suggests th at the disord er may be more frequent than the literature shows, pointing out th at a rhythm with a period of one yea r is difficult for both pat ient and doctor to perceive. Thi s, together with th e findings that these pat ients have relati vely milder hyperphagic, hyper sornnic, and anergic symptoms, may contri bute to these patient s being misdiagno sed or never tre at ed.
POTENTIAL RESEARCH PROBLEMS USING LIGHT TH ERAPY
In the ir discussion, Rosenthal and colleagues point out possible problems with the interpretation of their results. Th ese are: a) that th e news article ma y have screened for suggesta ble subjects who expected a similar result to th at described; b) that the dim (control) light could not be " blind" to the subj ects; c) th at sleep de privation in the second half of the night is known to have antidepressa nt effects (21) and since subjects were sometimes awakened in the morning for light thera py, this effect must be controlled for; and, finally, d) that a sea rch should be made for psychosocial vari able s, such as anniversa ry rea ction s and holiday depression.
In a recently reported study (5), Rosenthal an d colleag ues further studied the effects of light treatment in SAD, using a similarly designed stu dy with some notable exceptions: a) seven outpatients were studied as well as six additional inpatients, and b) sleep was monitored polysomnographically during the study. Pertinent high lights will be presented here. (The reader is referred to the original article for further details.) Using more rigorous statistical analysis than in their earlier st udy, Rosenthal and colleagues closely replicated their earlier findings of the a ntidepressa nt action of bright white light in SAD compared to dim light controls. No significa nt differences were noted comparing the response of outpatients versus inpatient s, nor were there any significant differences in the mean sleep time in subjects getting bright versus dim light treatment during either baseline, treatment, or withdrawal cond itions. Rosenthal admits that some phase advance of the sleep cycle (referred to in depth later in this review) occurred when subjects were awa kened at 5:00 A.M. for light th erapy; but argues that sleep deprivation or phase advancement cannot be sufficient to exp lain the noted antidepressant response since the sleep effects were present in both bright and dim light treatment settings, but only those subjects exposed to bright light treatment showed a significant antidepressant response. On the issue of patient expectations in the "nonblind" crossover aspect of the study, Rosenthal argues agai nst a place bo explanation of the study findings by emphasizing the similarity of first a nd second responses to bright light, the latency of the response a nd relapse (a few da ys), and the successful use of maintenance light therapy in four subjects throughout the winter (5). Rosenthal reports that although his group has successfully maintained a n a ntidepressant response using bright white light therapy in ten patients diagno sed with SA D, regular exposure is critical for maintenance with relapse occurring in a few days if light therapy is omitted.
Rosenthal concludes that a) Seasonal Affective Disord er is a subgroup of affective illness wherein susceptible patients show app arent react ivity to environmental factors , b) that preliminary evidence suggests that artificially man ipulat ing environmental light may be clinically useful in treating these pati ent s, and c) tha t fur ther work is required to validate SAD as a distinct clin ical syndrome.
A THEORETICAL MECHANISM OF ACTION OF LIGHT THERAPY
Understanding how light could effect depression involves relat ed resear ch in neuroanatomy, endocrinology, and in the physiology of biological rhythms as they relate to affective illness .
Many animal species show seasonal or circannual rh ythms th at a re known to control such phenomena as migration, breeding patterns, and hibernation ( 12) . T he control of these rhythms have been shown to be endogenous in origin, i.e., that they continue to manifest themselves in the absence of environmental stimuli, although environmental stimuli are known to influence or regulate the timing of these rhythms. Of these environmental stimuli, the photoperiod seems to be the most influential (2).
THE NEUROANATOMY OF BIOLOGICAL RHYTHMS
Circadian rhythms (meaning: of about 24 hours) have been studied in ma ny animal species, including man, and are known to occur in such physiological par a me-ters as cortisol secretion, fluctuations in body temperature, R EM sleep propensity, a nd melatonin secretion (12, 14, 15) . Ablative experiments have shown these rhythms to be controlled by an endogenous brain pacemaker located in the suprac hiasmatic nucle us (SCN) of the hypothalamous (15 , 16, 17) . This brain center rece ives neura l input from the retina via several neural tracts, of which the retinohypoth alamic tract has been shown to mediate the effects of light on biological rhythms (12 , 17) . Further neura l pathways have been shown connecting the SCN to the thorac ic spina l cord nucleii and, subsequently, the pineal gland via noradrenergic neurons tr aversing the superior cervical ganglion (17) . Hence, the effects of light impinging on the ret ina a re re layed via neural pathways to the CNS pacemaker for biological rh ythms a nd su bsequently to the pineal gland.
Embryologically the pinealacytes are known to have evolved fro m photoreceptor cells in lower animals smiliar to those found in the lateral eyes of certa in animals ( 16, 17) . In higher animals the pineal is no longer directly sensitive to ligh t; its effects require the above neural pathways to relay information about environm en ta l light (17) . The blinding of experimental animals, as well as a blat ion of th e SCN , pineal gland, or any of the neural connections between them, have been shown to prevent the regulatory effects of light on certain biological rhythms (12 ) .
THE PINEAL GLAND AND MELATONIN IN BIOLOGICAL RHYTHMS
The function of the pineal gland is a subject of conti nuing intensive study, particularly in relation to biological rhythms. The pine al gland is known to secrete indolamine hormones and certain peptides (14, 15, 16, 17, 18) . Melat onin, an indoleamine hormone synthesized from sera tonin, is secreted by the pineal glan d in a diurnal rhythm. Peak below levels occur during the nighttime sleep of hum a ns a nd during the nighttime active period of nocturnal animals (in the a bse nce of environmental light) (17) . Light impinging upon the retina is known to immed iat ely suppress the secretion of melatonin (16 , 17, 18) . Interestingly, humans seem to require ligh t of considerably higher intensity than a nima ls to suppress melat onin, perh aps d ue to man's adaptation to an artificially lit environment (20) . The function of melat onin is a subject of great speculation and few known fact s. Whether melatonin is a n endocrine messenger linking the light/dark cycle with biologic al rh ythms in hum an s remains a question under intensive study. Some studies do , however , demonstrat e such effects in animals.
Seasonal reproductive cycle s in animals are attributed to a ntigonadal properties of melatonin. At least one mechanism involves melatonin ch anging the sensitivity of gonadatropin control centers to negative feedback by steroid sex hormones (1 2). Thus, seasonal changes in the length of the photoperiod modulate blood levels of melatonin, which in turn controls seasonal reproductive cycles through its effect s on gonadatropic function .
Comparatively less is known about the function of melatonin in man . A few small studies have reported giving exogenous melatonin to humans to test its effects on Parkinson's Disease and depression . Using doses up to six gr ams per day, no beneficial effect was noted in Parkinson's Disease (21) and increased dysphoria was noted in a study of eight depressed patients given melatonin (22) . Th e most frequent effects noted were sedation and somnolence (21, 22) .
In summary, light has been proven to regul at e th e biological rhythm of seasonal reproductive cycles in animals. Information about fluctu at ions in environmental light is relayed from the eye to the circ adi an pacemaker (S e N ) a nd pineal gland . Thus , light indirectly regulates pineal melatonin secretion which in turn alters the gonadotropic control of reproductive cycles. Whether an analogous mechani sm affects those biological rhythms relevant to depression remains speculative a t thi s time.
BIOLOGICAL RHYTHMS IN DEPRESSION
The hypothesis that circadian rhythm disturbance could be involved in affective illness originall y evolved from consideration of four clinic al fea tures of depression: early morning awakening, diurnal vari ation of symptom severity, season alit y, and cyclicity of the illness (14) .
When the sleep architecture of normal subjects is sa mpled du ring short naps around the clock, REM sleep also exhibits a circadian rhythm with a REM sleep peak in the midmorning and a minimum in the late afternoon. Thus R EM sleep in normal subjects predominates in the later half of the sleep cycle.
The sleep EEGs of depressed patients show that R EM sleep occurs earlier in the sleep period than in nondepressed controls (23) . The sleep disturba nces seen in depression with shortened REM latency, short tot al sleep ti me, a nd early morning awakening can be mimicked in norm al subj ects by shifti ng the onset of sleep from 10 P.M . to 10 A.M . Wehr and colleagues thus specul ated th at the circa dian rhythm peak of REM sleep may occur abnormall y early in depression, that is, phase adva nced, relative to the sleep period . Wehr states: "If thi s inference is relevant to the etiology of affective illness, advancing a patient's sleep period by severa l hour s should alter the internal phase relationship between the circadian sleep-wake cycle a nd oth er circa dian rhythms (such as temperature or the probability of REM sleep) so as to norm alize both sleep architecture and mood" (23) . This observation led Wehr a nd colleag ues to experimentally phase advance a depressed patient's sleep cycle by six hours, that is, from the conventional 11:00 P.M. to 7:00 A.M. sleep period to a 5:00 P.M. to 1:00 A.M . sleep period. These investigators reported a complete remission of depressive symptoms followed by a slight hypomanic state. Two weeks later the pat ient relapsed and a second six-hour phase shift produced a similar remis sion. Wehr , et ai, reported similarly successful results with three additional patients using phase advance therapy (19) .
Thus, a particular imbalance in the temporal relationship of REM sleep to the total sleep cycle is postulated to cause depression.
ENVIRONMENTAL LIGHT ENTRAINS BIOLOGICAL RHYTHMS IN MAN
Several investigators have shown that if hum an subjects are kept in a rtificially controlled constant light or dark environments, the circ adian rh ythms cont rolling body temperature, cortisol secretion, and REM sleep propensit y continue to show endogenous (or free-running) cycles which a re slightl y longer than the expected 24-hours, e.g., 25-28 hours (12, 14, 24) . This suggests that human, as well as animal circadian rhythms, a re continually adjusted to maintain a 24-hour period icy by the preva iling light/dark cycle .
DESYNCHRONIZED CIRCADIAN PACEMAKERS IN DEPRESSION
Goodwin a nd colleag ues post ulate a more complex model consisting of two pacemakers or oscillators; a strong one controlling body temperature, R EM sleep propensity a nd cortisol secretion; and a weak one controlling the sleep cycle an d sleep related neuroendocrine activity (14) .
Goodwin states that: "Light acting on circadian oscillators is the basis of seasonal a nd annual biological rhythms. Phase shift experiments and rapid tran smer idia n tr avel can temporarily dist urb the normal pha se relationships betwe en the two circadian oscillators an d their overt rh ythms. It is reasonable to assume tha t such a system of oscillators may be altered by disease or by treatment interventions. Th e intrinsic period of the oscillators could be altered or changes could occur in the coupling to the external da y/ night cycle" (14) .
SUMMARIZI NG TH E PROPOSED ANTI DEPRESSANT ACTION OF LIGHT THERAPY
Individ uals with SAD are postulated to have some impairme nt in the coupling of their biological rhythms with the day/night cycle such that th e shorte r days of winter ca use the biological rhythm for R EM sleep to peak abnormally earl y in the sleep cycle, prod ucing depression according to the model proposed by Wehr, et al (23) . If such a mecha nism is correct, th en artificially exte nding the photoperiod to one "seen" by the biological rhythm cont rol system as a spring day could norm ali ze the R EM sleep a bnormality, thus relieving depression in SAD. A mechanism similar to the retinaSeN-pineal-melatonin axis out lined in the control of mammali an seaso nal reproductive cycles may underlie the manner in which shorter photoperiods alter biological rhythms and hence mood . Presenting the retina with light of a desired intensity and du ration could then be potentially used to normalize the biological rhythms altered in SAD.
INTEGRATING BIOLOGICAL RHYTHMS WITH OTHER THEORIES OF DEPRESSION
Goodwi n noted in animal studies that the number of va rious brain receptors (a lpha and beta adre nergic, cholinergic, dopaminergic, opiate, a nd benzodiazepine receptors) also show circadia n rhythm fluctuations a nd that chronicall y adminis tering imipramine (a tricyclic) or chlorgyline (an MAOI inhibitor) pha se dela yed the diurnal variation in all receptors to various degrees, e.g., peak alpha adre nergic receptor binding occurred twelve hours later in drug treated patients th an in untr eated controls (other wave characteristics were also changed) (14 ,25) . Lithium has also been shown to slow circadian rhythms in animals (25) . These studies suggest that antidepressant drugs may alleviate depression by phase delaying the depressed pat ient's already pha se advanced circadian rhythms, restoring them to a more homeostat ic sta te.
Lingjaerde, in 1983, reviewed the biochemistry of depression (26) , citing the well known biogenic amine theories, the more recent neuroendocrine findings in depression that underlie the use of the dexamethasone suppression test (DST) a nd the th yrotropin releasing hormone (TRH) test. He also includes the question of biological rhythms, suggesting that they not be viewed separ ately, but integrated with existing theories. Lingjaerde states: "It is not unreasonable to assume that the function of the hypothalamic nucleus is dependent on monoaminergic mech an isms. If so, general hypofunction, or inherent lability in noradrenergic or seratonergic functions may well predispose to disturbances in the regulation of circ adian rhythms. Thus it is clear that disturbed biological rhythms are to be regarded . . . as a distu rba nce that is most intimately connected with disturbances in monoaminergic a nd neur oend ocrinological functions" (26) .
DISCUSSION
Treating depression in properly diagnosed patients with ligh t thera py is a n excit ing concept to potentiall y add to the psychi atrist's ar mamentari um. Mu ch research remains to be done to confirm previous work with larger num bers of subjects in controlled studies, selecting subjects with seasona l symptoms from lar ger group s of depressed patients, and devising reliable ways to select out those pa tients with seasonally dependent psychosocial determinants of depression.
Perhaps even more significant are the implications of the theoretical mecha nism of action of light therapy in the etiology of depression. Circadi an rhyth m research in affective illness offers, in the author's opinion , the most novel conceptualization of affective illness since the biogenic amine hypothesis. The level of knowledge, at this time, of even the most fundamental aspects of the eti ology of depression is by no mean s clear. Current biological research seems focused on neurotran smitt er altering drugs and receptor physiolog y. Could some of thi s research explain more of the complete picture if data were also viewed from the perspective of alte red biological rhythms? Anna Wirz-Justice points out that biochemical determinations such as platelet sera tonin concentrations reveal new dimensions when a na lyzed with circa dian (as well as circannual) variability in mind as opposed to single point determinati ons (7) . Could, for example, the lag time in the onset of action of tricyclic antidepressants be explai ned by the time required for these drugs to norm alize the biological rhy thm distu rbances of depression? Do a ntidepressa nt drugs work by acting on th e a minergic neur al systems that are known to control biological rh ythms, as Lingjaerde suggests? Th e fac ts tha t a) the SCN has the highest concentration of seratonergic neurons in th e hypot halamous, b) that the control of melatonin secretion is a noradrenergic syste m, a nd c) that the number of monoaminergic receptors t hemselves show ci rcadian rhythm period icy that is a lt ere d by a nti d ep ressant drugs (includ ing lit hi u m in ra ts) a ll suggest some point s of potential integra t ion between biogen ic a m ines, rec eptor ph ysiology, and biolo gical rh ythms.
Future depression research will undoubtedly sho w new perspect ives in th e d esign of st ud ies th at more fully integrate th e tenets of biologi cal rhythm re search with the more prevalent re search ba sed on t heories of sy naptic ph ysiology.
